Triangle Securities Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,173
Closed -$445K 139
2017
Q3
$445K Sell
2,173
-55
-2% -$12.8K 0.26% 93
2017
Q2
$542K Buy
2,228
+185
+9% +$43.5K 0.36% 80
2017
Q1
$488K Buy
2,043
+167
+9% +$38.9K 0.31% 86
2016
Q4
$394K Buy
1,876
+163
+10% +$33.8K 0.26% 93
2016
Q3
$395K Buy
1,713
+90
+6% +$22K 0.27% 93
2016
Q2
$375K Buy
+1,623
New +$374K 0.28% 89

Other funds holding AGN

Triangle Securities Wealth Management's AGN Position: Q4 2017 in Review

Triangle Securities Wealth Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 2,173 shares — an estimated $445K sold.

Triangle Securities Wealth Management first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $542K in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Triangle Securities Wealth Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Triangle Securities Wealth Management sold 2,173 Allergan plc shares in Q4 2017, an estimated $445K.
  • Triangle Securities Wealth Management first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Triangle Securities Wealth Management's Allergan plc position peaked at $542K in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Triangle Securities Wealth Management's 13F filing for Q4 2017, filed 10 Jan 2018.